Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Gauthier

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Neuro-Oncology|August 2, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumorsGrégory Thomson, Mathilde Filser, Léa Guerrini-Rousseau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2011
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumorFranck Bourdeaut, Delphine Lequin, Laurence Brugières, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 CarriersJulie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Pediatric Blood & Cancer|April 7, 2021
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsGianni Bisogno, Sabine Sarnacki, Teresa Stachowicz-Stencel, et al.
BMJ (Clinical Research Ed.)|September 8, 2012
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)Anouk Pijpe, Nadine Andrieu, Douglas F Easton, et al.
JAMA Ophthalmology|June 18, 2025
Uveal Melanoma and the Lynch Syndrome Tumor SpectrumAnaïs Le Ven, Marie-Charlotte Villy, André Bortolini Silveira, et al.
Journal of the National Cancer Institute|December 5, 2002
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersSteven A Narod, Marie-Pierre Dubé, Jan Klijn, et al.
Neuro-Oncology Advances|July 4, 2024
Medulloblastomas with <i>ELP1</i> pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age windowLéa Guerrini-Rousseau, Julien Masliah-Planchon, Mathilde Filser, et al.
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Neuro-Oncology|August 2, 2024
Postzygotic mosaicism of SMARCB1 variants in patients with rhabdoid tumors: A not-so-rare condition exposing to successive tumorsGrégory Thomson, Mathilde Filser, Léa Guerrini-Rousseau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2011
Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumorFranck Bourdeaut, Delphine Lequin, Laurence Brugières, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2015
Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 CarriersJulie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, et al.
Pediatric Blood & Cancer|April 7, 2021
Pleuropulmonary blastoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendationsGianni Bisogno, Sabine Sarnacki, Teresa Stachowicz-Stencel, et al.
BMJ (Clinical Research Ed.)|September 8, 2012
Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)Anouk Pijpe, Nadine Andrieu, Douglas F Easton, et al.
JAMA Ophthalmology|June 18, 2025
Uveal Melanoma and the Lynch Syndrome Tumor SpectrumAnaïs Le Ven, Marie-Charlotte Villy, André Bortolini Silveira, et al.
Journal of the National Cancer Institute|December 5, 2002
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersSteven A Narod, Marie-Pierre Dubé, Jan Klijn, et al.
Neuro-Oncology Advances|July 4, 2024
Medulloblastomas with <i>ELP1</i> pathogenic variants: A weakly penetrant syndrome with a restricted spectrum in a limited age windowLéa Guerrini-Rousseau, Julien Masliah-Planchon, Mathilde Filser, et al.
Breast Cancer Research : BCR|April 20, 2012
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriersAna-Teresa Maia, Antonis C Antoniou, Martin O'Reilly, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
Pageof 11